Benign Prostatic Hyperplasia Treatment Market Segmentation by Treatment Type [Drug {Alpha Blockers (Alfuzosin, Doxazosin, Tamsulosin, and Terazosin), 5-Alpha Reductase Inhibitors (Finasteride and Dutasteride), and Phosphodiesterase 5 inhibitors} and Surgery (TURP, TUMT, TUNA, Laser, Urolift Therapy, Prostatic Stenting, Rezum Therapy and Others)]; and by Application (General Medical & Surgical Hospitals, Clinics, and Others) – Global Demand Analysis and Opportunity Outlook 2021-2029